Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) – Equities research analysts at Leerink Swann lifted their FY2018 EPS estimates for shares of Allscripts Healthcare Solutions in a report issued on Thursday. Leerink Swann analyst D. Larsen now expects that the software maker will post earnings per share of $0.59 for the year, up from their prior forecast of $0.57. Leerink Swann currently has a “Market Perform” rating and a $13.00 target price on the stock.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last announced its quarterly earnings data on Thursday, August 3rd. The software maker reported $0.11 EPS for the quarter, missing the Zacks’ consensus estimate of $0.15 by $0.04. The firm had revenue of $426.10 million during the quarter, compared to analyst estimates of $424.94 million. Allscripts Healthcare Solutions had a negative net margin of 11.54% and a positive return on equity of 5.97%. Allscripts Healthcare Solutions’s revenue for the quarter was up 10.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.14 EPS.

ILLEGAL ACTIVITY WARNING: This article was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another publication, it was illegally copied and republished in violation of international copyright and trademark law. The original version of this article can be accessed at https://www.thecerbatgem.com/2017/08/16/fy2018-eps-estimates-for-allscripts-healthcare-solutions-inc-mdrx-increased-by-leerink-swann.html.

Several other research firms have also recently commented on MDRX. Morgan Stanley upped their target price on shares of Allscripts Healthcare Solutions from $11.00 to $12.00 and gave the stock an “underweight” rating in a research report on Monday, August 7th. Zacks Investment Research upgraded shares of Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a research report on Wednesday, April 19th. Maxim Group restated a “buy” rating and issued a $16.00 target price on shares of Allscripts Healthcare Solutions in a research report on Monday, May 15th. Piper Jaffray Companies restated a “hold” rating and issued a $14.00 target price on shares of Allscripts Healthcare Solutions in a research report on Friday, July 21st. Finally, Citigroup Inc. upped their target price on shares of Allscripts Healthcare Solutions from $13.00 to $14.00 and gave the stock a “neutral” rating in a research report on Monday, August 7th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and ten have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of $14.59.

Shares of Allscripts Healthcare Solutions (NASDAQ MDRX) traded up 0.93% during midday trading on Monday, reaching $12.97. 1,608,095 shares of the company were exchanged. The stock’s market capitalization is $2.34 billion. Allscripts Healthcare Solutions has a 52-week low of $9.80 and a 52-week high of $13.70. The company’s 50-day moving average price is $12.50 and its 200 day moving average price is $12.19.

A number of hedge funds have recently added to or reduced their stakes in MDRX. TimesSquare Capital Management LLC raised its stake in Allscripts Healthcare Solutions by 1,322.5% in the second quarter. TimesSquare Capital Management LLC now owns 4,039,900 shares of the software maker’s stock valued at $51,549,000 after buying an additional 3,755,900 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in Allscripts Healthcare Solutions by 26.9% in the second quarter. Dimensional Fund Advisors LP now owns 9,171,285 shares of the software maker’s stock valued at $117,026,000 after buying an additional 1,943,496 shares in the last quarter. First Trust Advisors LP raised its stake in Allscripts Healthcare Solutions by 48.0% in the first quarter. First Trust Advisors LP now owns 5,855,944 shares of the software maker’s stock valued at $74,253,000 after buying an additional 1,898,007 shares in the last quarter. Mesirow Financial Investment Management Equity Management acquired a new stake in Allscripts Healthcare Solutions during the second quarter valued at approximately $18,797,000. Finally, Fiduciary Management Inc. WI raised its stake in Allscripts Healthcare Solutions by 28.5% in the first quarter. Fiduciary Management Inc. WI now owns 6,045,110 shares of the software maker’s stock valued at $76,652,000 after buying an additional 1,341,870 shares in the last quarter.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Receive News & Stock Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related stocks with our FREE daily email newsletter.